Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Texas Children's Hospital, 1102 Bates St. Ste. C1025, Houston, TX, 77030, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Int J Hematol. 2019 Jul;110(1):95-101. doi: 10.1007/s12185-019-02626-w. Epub 2019 Mar 23.
Cerebral cavernous malformation 3 (CCM3) is a vascular malformation disorder causing brain slow-flow vascular parenchymal lesions. These lesions are the result of variants in the Programmed Cell Death Protein 10 (PDCD10) gene, located on 3q26.1. We report an 8-month-old patient who was presented with seizures and intracranial abscesses and was found to have a variant of PDCD10 on whole exome sequencing, representing, to our knowledge, the youngest case of CCM3 described in the literature. Her clinical course was complicated by the development of neutropenia, requiring granulocyte colony-stimulating factor, and thrombocytopenia, requiring intermittent platelet transfusions, with later development of B acute lymphoblastic leukemia 2 years after initial presentation. This case represents the first description in the literature of hematologic complications in the setting of CCM3. We hypothesize that these hematological manifestations are the result of alterations in the actin and microtubule cytoskeleton, affecting the process of hematopoiesis in a similar fashion to the documented effect of the PDCD10 variant on neuronal migration.
脑静脉血管畸形 3 型(CCM3)是一种血管畸形疾病,可导致脑慢血流血管实质病变。这些病变是程序性细胞死亡蛋白 10(PDCD10)基因变异引起的,该基因位于 3q26.1。我们报告了一例 8 个月大的患者,其表现为癫痫和颅内脓肿,并在全外显子组测序中发现 PDCD10 变异,据我们所知,这是文献中描述的最年轻的 CCM3 病例。她的临床病程复杂,出现中性粒细胞减少症,需要粒细胞集落刺激因子治疗,血小板减少症,需要间歇性血小板输注,最初表现后 2 年发展为 B 型急性淋巴细胞白血病。该病例代表了文献中首次描述 CCM3 伴血液学并发症。我们假设这些血液学表现是肌动蛋白和微管细胞骨架改变的结果,以类似于 PDCD10 变异对神经元迁移的已有影响的方式影响造血过程。